Ping An Healthcare and Technology Company Limited (PIAHY) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ping An Healthcare and Technology Company Limited (PIAHY) trades at $1.88 with AI Score 52/100 (Grade B). Ping An Healthcare and Technology Company Limited operates a comprehensive online healthcare services platform in the People's Republic… Market cap: $1000M, Sector: Healthcare.
Price as of Jul 22, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for PIAHY: PIAHY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates PIAHY against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
PIAHY: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Ping An Healthcare and Technology Company Limited (PIAHY) Healthcare & Pipeline Overview
Ping An Healthcare and Technology Company Limited is a prominent online healthcare services platform in China, providing comprehensive digital medical consultations, hospital referrals, and consumer health packages. It integrates healthcare products, wellness programs, and technology services, positioning itself as a key player in the evolving digital health ecosystem within the Chinese market.
What Is the Investment Thesis for PIAHY?
Ping An Healthcare and Technology Company Limited presents an investment thesis rooted in the accelerating digital transformation of China's healthcare sector and its comprehensive, integrated platform approach. The company's value drivers include its extensive online medical services, diverse product offerings, and strategic integration of health management and insurance agency functions. With a market capitalization of $1000M, a P/E ratio of 44.56, and a gross margin of 32.4%, the company demonstrates a growth-oriented valuation and operational efficiency. Key growth catalysts involve the increasing adoption of telemedicine in China, the expansion of its consumer healthcare packages, and the potential for enhanced cross-selling across its healthcare products and wellness services. The company's 6.9% profit margin indicates room for operational leverage as its user base and service offerings scale. However, potential risks include intense competition, evolving regulatory landscapes in China, and the execution risk associated with continuous platform development and service expansion.
Based on FMP financials and quantitative analysis
PIAHY Key Highlights
- Market Capitalization: $1.59 billion, indicating its scale within the healthcare information services sector.
- Price-to-Earnings (P/E) Ratio: 44.56, suggesting investor expectations for future growth and profitability.
- Gross Margin: 32.4%, reflecting the profitability of its core services and product sales before operating expenses.
- Profit Margin: 6.9%, demonstrating its net earnings efficiency after all expenses, including taxes.
- Employee Base: 1,563 employees, supporting its extensive online platform and service delivery operations across China.
Who Are PIAHY's Competitors?
PIAHY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| NUTX Nutex Health, Inc. | $157.21 | -6.57% | $936M | 94 |
| HSTM HealthStream, Inc. | $26.89 | -3.41% | $786M | 91 |
| RSLBF RaySearch Laboratories AB (publ) | $18.85 | +0.00% | $639M | 57 |
| PHR Phreesia, Inc. | $10.01 | -5.57% | $619M | 55 |
| ACCD Accolade, Inc. | $7.02 | +0.00% | $576M | 55 |
| OMCL Omnicell, Inc. | $40.86 | -2.32% | $1.86B | 82 |
| NRC National Research Corporation | $21.59 | +0.51% | $487M | 70 |
| KSIOF Kneat.com, Inc. | $4.60 | +0.14% | $442M | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PIAHY's Key Strengths?
- Comprehensive online healthcare platform offering a diverse range of medical, product, and wellness services.
- Established presence and brand recognition within the large Chinese healthcare market.
- Integration of multiple service lines, including online consultations, hospital services, and an insurance agency.
- Strong technological capabilities in application development and platform operation.
What Are PIAHY's Weaknesses?
- High Price-to-Earnings (P/E) ratio of 44.56, suggesting high growth expectations that may be challenging to consistently meet.
- Profit margin of 6.9% indicates potential for improved operational efficiency and profitability.
- Reliance on the Chinese market exposes the company to specific regional regulatory and economic risks.
- Disclosure status on OTC market is 'Unknown', which can impact investor confidence and transparency.
What Could Drive PIAHY Stock Higher?
- Expansion of online consultation services to new regions within China, potentially increasing user base and service utilization.
- Increasing adoption of digital health solutions by Chinese consumers, driving demand for the company's online platform and services.
- Introduction of new standardized consumer healthcare service packages, aimed at attracting specific demographic segments and increasing average revenue per user.
- Development and integration of advanced AI-powered health management tools and personalized content, enhancing user engagement and retention on the platform.
- Potential strategic partnerships or acquisitions within the Chinese healthcare technology sector to expand market reach or service capabilities.
What Are the Key Risks for PIAHY?
- Regulatory changes in China's healthcare or internet sectors, which could impact the company's operational model, data handling, or service offerings.
- Intense competition from both established technology giants and emerging specialized healthcare platforms in the rapidly evolving Chinese market.
- Data privacy and security breaches, which could erode user trust, lead to significant financial penalties, and damage the company's reputation.
- Economic slowdown or shifts in consumer spending patterns in China, potentially affecting demand for discretionary healthcare and wellness products and services.
- Fluctuations in the exchange rate between the Chinese Yuan and the U.S. Dollar, which could negatively impact the value of ADRs for U.S. investors.
What Are the Growth Opportunities for PIAHY?
- Expansion of Online Medical Services: The demand for convenient and accessible healthcare in China continues to grow, presenting a significant opportunity for Ping An Healthcare to deepen its penetration in existing markets and potentially expand into underserved regions. By enhancing its online consultation capabilities, improving hospital referral networks, and streamlining appointment processes, the company can capture a larger share of the digital health market. This expansion is supported by ongoing technological advancements and increasing consumer comfort with virtual healthcare interactions, driving user growth and service utilization over the next 3-5 years.
- Integration of Consumer Healthcare Packages: Developing and promoting more standardized service packages that bundle various healthcare institution services offers a robust growth pathway. These packages can be tailored to specific demographic needs, chronic disease management, or preventative care, allowing for higher average revenue per user and stronger customer loyalty. By integrating services like health screenings, specialist consultations, and follow-up care into cohesive offerings, Ping An Healthcare can tap into the substantial market for proactive health management, with growth expected to accelerate over the medium term.
- Diversification of Healthcare and Wellness Products: The burgeoning health-conscious consumer base in China provides a fertile ground for expanding the range of healthcare and wellness products available through the platform. This includes broadening offerings in medicines, health supplements, medical devices, fitness equipment, and personal care items. By leveraging its existing user base and data insights, Ping An Healthcare can curate and market products that align with user needs and preferences, driving e-commerce revenue growth. This segment is expected to see sustained growth over the next 5-7 years as disposable incomes rise and health awareness increases.
- Enhanced Health Management and Wellness Interaction Services: Investing in and expanding AI-driven personalized wellness programs, interactive health tools, and tailored content can significantly improve user engagement and retention. By offering proactive health advice, activity tracking, and educational resources, Ping An Healthcare can create a sticky ecosystem that keeps users engaged beyond episodic medical needs. This strategy fosters a stronger community around health and wellness, potentially leading to increased platform usage and cross-selling opportunities, with continuous development expected over the long term.
- Leveraging Insurance Agency and Technology Services: Further integrating its insurance agency operations with its healthcare platform allows Ping An Healthcare to offer bundled health and insurance solutions, creating a unique value proposition. This synergy can attract new users seeking comprehensive coverage and health management. Additionally, commercializing its proprietary technology services, such as application development and operational expertise, to other healthcare providers or institutions could open new B2B revenue streams. This strategic leveraging of internal capabilities is a long-term growth driver, capitalizing on the broader digital transformation of the healthcare industry.
What Opportunities Does PIAHY Have?
- Growing demand for digital healthcare solutions and telemedicine services in China.
- Expansion into new therapeutic areas or specialized health management programs.
- Strategic partnerships with other healthcare providers or technology companies to broaden reach and offerings.
- Leveraging AI and big data analytics to enhance personalized health management and user engagement.
What Threats Does PIAHY Face?
- Intense competition from domestic and international technology giants and specialized healthcare platforms.
- Evolving and potentially restrictive regulatory landscape in China's healthcare and internet sectors.
- Potential for data security breaches or privacy concerns, eroding user trust and incurring penalties.
- Economic slowdown in China impacting consumer discretionary spending on healthcare and wellness products.
- Currency fluctuation risks for ADR holders due to exposure to the Chinese Yuan.
What Are PIAHY's Competitive Advantages?
- Comprehensive integrated platform offering a wide array of services from online consultation to product sales and insurance, creating a holistic user experience.
- Established brand presence and significant user base within the highly competitive Chinese online healthcare market.
- Extensive network of healthcare institutions and medical professionals supporting its referral, appointment, and second opinion services.
- Proprietary technology and application development capabilities that underpin its digital platform and service delivery.
- Synergistic relationship with its insurance agency, potentially offering bundled health and financial solutions.
What Does PIAHY Do?
Ping An Healthcare and Technology Company Limited, incorporated in 2014 and headquartered in Shanghai, China, has rapidly established itself as a significant operator in the People's Republic of China's burgeoning online healthcare sector. The company's core offering revolves around a comprehensive online healthcare services platform designed to cater to a wide spectrum of consumer health needs. This platform provides essential online medical services, including virtual consultations with medical professionals, streamlined hospital referral and appointment booking processes, assistance with inpatient arrangements, and access to crucial second opinion services. Beyond direct medical care, Ping An Healthcare extends its reach into consumer healthcare by offering various standardized service packages that integrate offerings from multiple healthcare institutions, aiming to provide holistic and convenient health solutions. Further diversifying its business, the company is a significant provider of healthcare products, encompassing a range of medicines, health supplements, and medical devices. It also caters to the growing wellness market with products like fitness equipment, accessories, and personal care items. To foster a proactive approach to health, Ping An Healthcare offers extensive health management and wellness interaction services, which include personalized wellness programs, interactive tools and activities, and tailored health content. The company's operational scope also includes specialized medicine marketing services, advanced technology services, application development and operation capabilities, and the provision of hospital and clinic services. Additionally, it operates an insurance agency, leveraging synergies within the broader Ping An ecosystem to offer integrated health and financial solutions, solidifying its position as a multi-faceted digital health provider in China.
What Products and Services Does PIAHY Offer?
- Operates a comprehensive online healthcare services platform in the People's Republic of China.
- Offers online medical consultations, including diagnosis and treatment advice from healthcare professionals.
- Facilitates hospital referrals, appointment scheduling, and arrangements for inpatient services.
- Provides second opinion services for patients seeking additional medical perspectives.
- Sells a wide range of healthcare products, including medicines, health supplements, and medical devices.
- Offers wellness products such as fitness equipment, accessories, and personal care items.
- Delivers health management and wellness interaction services, including personalized programs and content.
- Provides medicine marketing services, technology services, application development, and operates an insurance agency.
How Does PIAHY Make Money?
- Generates revenue from online medical services through consultation fees and service charges for referrals and appointments.
- Earns income from the direct sale of healthcare products, health supplements, and medical devices via its e-commerce platform.
- Monetizes consumer healthcare service packages that integrate various institutional services for a bundled fee.
- Receives fees for health management and wellness interaction services, including subscriptions or program participation.
- Derives revenue from medicine marketing services, technology solutions provided to third parties, and commissions from its insurance agency operations.
What Industry Does PIAHY Operate In?
Ping An Healthcare and Technology Company Limited operates within the dynamic Medical - Healthcare Information Services industry in the People's Republic of China. This sector is characterized by rapid digital adoption, driven by increasing consumer demand for convenient and accessible healthcare solutions, alongside government initiatives promoting telemedicine and digital health. The competitive landscape includes traditional healthcare providers developing digital offerings, specialized telemedicine platforms, and large technology companies entering the health space. Ping An Healthcare distinguishes itself through its comprehensive, integrated platform, which spans online consultations, hospital services, consumer health packages, and a diverse array of healthcare and wellness products. This broad ecosystem approach positions the company to capture multiple revenue streams and build a sticky user base in a market that values holistic health solutions and convenience.
Who Are PIAHY's Key Customers?
- Individual consumers in China seeking convenient online medical consultations and health advice.
- Patients requiring assistance with hospital referrals, appointment bookings, or inpatient arrangements.
- Consumers purchasing a variety of healthcare products, health supplements, and medical devices.
- Individuals interested in wellness products, fitness equipment, and personal care items.
- Users engaging with health management programs, wellness tools, and personalized health content.
ROE 4%Key Financial Metrics
Return on equity for Ping An Healthcare and Technology Company Limited stands at 3.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.9%, showing how much profit it generates from its asset base. PIAHY trades at a trailing price-to-earnings ratio of 36.42, above the Healthcare sector average of ~23x. Its free cash flow yield is 2.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.70 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.7%, the inverse of the P/E and a quick read on earnings relative to price.
Ping An Healthcare and Technology Company Limited (PIAHY) Valuation Context
Valued at $1000M, PIAHY is classified as a small-cap stock. Relative to its peer group, PIAHY's quantitative score of 52/100 is below the peer average of 70/100.
Company Profile
Ping An Healthcare and Technology Company Limited operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Shanghai, CN. The company is led by CEO Mingke He. PIAHY has traded publicly since 2020.
F-Score 5/9Financial Health
Ping An Healthcare and Technology Company Limited's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.82 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project Ping An Healthcare and Technology Company Limited revenue of about $5.94B for fiscal 2026, with EPS near $0.00. The estimate reflects 13 contributing analysts.
PIAHY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- AI analysis temporarily unavailable
- Check back shortly for updated insights
- Market sentiment data being refreshed
- Community discussions being analyzed
Bear Case
- AI analysis temporarily unavailable
- Check back shortly for updated insights
- Risk factors being evaluated
- Market concerns being processed
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
PIAHY Latest News
No recent news available for PIAHY.
PIAHY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PIAHY.
Price Targets
Wall Street price target analysis for PIAHY.
PIAHY MoonshotScore
What does this score mean?
The MoonshotScore rates PIAHY 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Mingke He
Unknown
Unknown. The provided data indicates Mingke He manages 1,563 employees at Ping An Healthcare and Technology Company Limited, but specific details regarding career history, education, or previous roles are not available.
Track Record: Unknown. While Mingke He leads the company, specific achievements, strategic decisions, or company milestones directly attributable to their leadership are not detailed in the provided source information.
Ping An Healthcare and Technology Company Limited ADR Information Unsponsored
Ping An Healthcare and Technology Company Limited trades as an American Depositary Receipt (ADR) under the ticker PIAHY. An ADR is a certificate issued by a U.S. depositary bank representing shares of a foreign company's stock. It allows U.S. investors to buy shares in foreign companies on U.S. exchanges, simplifying international investment. For PIAHY, each ADR represents a certain number of underlying shares of its home market stock (PIAH) traded in Shanghai, China.
- Home Market Ticker: Shanghai, CN
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: PIAH
PIAHY OTC Market Information
Ping An Healthcare and Technology Company Limited trades on the OTC market under the 'OTC Other' tier. The OTC (Over-The-Counter) market is a decentralized market where securities are traded directly between two parties, rather than through a centralized exchange like the NYSE or NASDAQ. The 'OTC Other' tier, also known as the Pink Sheets, represents companies that do not meet the minimum disclosure requirements for OTCQX or OTCQB tiers. This means there is generally less publicly available financial information and regulatory oversight compared to exchange-listed stocks, or even higher OTC tiers, which can impact transparency and investor confidence.
- OTC Tier: OTC Other
- Limited Public Information: The 'Unknown' disclosure status can lead to a lack of comprehensive and timely financial or operational data, making informed investment decisions difficult.
- Lower Liquidity: Trading on the 'OTC Other' tier often results in lower trading volumes and wider bid-ask spreads, making it harder to buy or sell shares efficiently.
- Price Volatility: Due to lower liquidity and less transparency, OTC Other stocks can experience higher price volatility compared to exchange-listed securities.
- Regulatory Oversight: The 'OTC Other' tier has less stringent regulatory requirements than major exchanges, offering fewer investor protections.
- Perception Risk: Trading on the lowest OTC tier can carry a perception of higher risk among institutional investors, potentially limiting broader market interest.
- Verify the company's official website and investor relations section for any available financial reports or announcements.
- Research the company's business operations and market position in China through independent third-party sources.
- Assess the trading volume and bid-ask spread to understand the stock's liquidity before committing capital.
- Investigate any news or regulatory filings from the company's home market (Shanghai) for additional insights.
- Understand the specific risks associated with investing in a Chinese company via an OTC-traded ADR.
- Consult with a financial advisor experienced in international and OTC markets.
- Evaluate the company's competitive landscape and growth prospects based on available industry data.
- The company is incorporated in 2014 and headquartered in Shanghai, China, indicating a formal corporate structure.
- It operates a comprehensive online healthcare services platform, suggesting a tangible business model and operations.
- The company has 1,563 employees, indicating a significant operational scale and workforce.
- Its association with the 'Ping An' name, a prominent financial and insurance group in China, may lend some credibility.
- The company's detailed business description outlines specific products and services, reflecting active operations.
What Investors Ask About Ping An Healthcare and Technology Company Limited (PIAHY) — Healthcare
What does the AI Score mean for PIAHY?
PIAHY holds an AI Score of 52/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. Ping An Healthcare and Technology Company Limited operates a comprehensive online healthcare services platform in the People's Republic of China. It offers a wide array of services including online …
What are the key growth opportunities for PIAHY in healthcare?
Ping An Healthcare and Technology Company Limited has several key growth opportunities within the dynamic Chinese healthcare market. One significant area is the continued expansion and deepening of its online medical services, leveraging the increasing adoption of telemedicine across China. This includes enhancing its consultation capabilities and expanding its network of affiliated hospitals and clinics for referrals.
What revenue streams does Ping An Healthcare and Technology Company Limited have in healthcare?
Ping An Healthcare and Technology Company Limited generates revenue through a multi-faceted approach within the healthcare sector. Its primary revenue streams include fees from online medical services, such as charges for online consultations, hospital referrals, appointment bookings, and second opinion services.
How does PIAHY differentiate itself in the competitive Chinese online healthcare market?
Ping An Healthcare and Technology Company Limited differentiates itself in the highly competitive Chinese online healthcare market through its comprehensive and integrated platform approach. Unlike many specialized providers, PIAHY offers a holistic ecosystem that spans online medical consultations, hospital referrals, consumer healthcare packages, a diverse range of healthcare and wellness products, and health management services.
What are the key factors to evaluate for PIAHY?
Ping An Healthcare and Technology Company Limited (PIAHY) holds an AI score of 52/100 (moderate). Not financial advice.
How frequently does PIAHY data refresh on this page?
PIAHY's price was last updated on Jul 22, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven PIAHY's recent stock price performance?
Ping An Healthcare and Technology Company Limited (PIAHY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive online healthcare platform offering a diverse range of medical, product, and wellness services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider PIAHY overvalued or undervalued right now?
Ping An Healthcare and Technology Company Limited (PIAHY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research PIAHY before investing?
Before investing in Ping An Healthcare and Technology Company Limited (PIAHY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived solely from the provided source data.
- Specific details on CEO background, track record, and tax implications for ADRs are not available in the source data and are marked as 'Unknown' or 'null'.
- Competitor information was not provided in the source data, thus marked as 'Unknown'.